• FirefoxInstall the new Firefox »
  •  Dow Down 0.80% Nasdaq Down 0.92%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.48 Down 0.00(0.37%) 10:28AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.49
    Open:0.48
    Bid:0.49 x 100
    Ask:0.49 x 600
    1y Target Est:3.00
    Beta:0.57
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:0.48 - 0.50
    52wk Range:0.48 - 1.45
    Volume:52,782
    Avg Vol (3m):729,008
    Market Cap:43.61M
    P/E (ttm):N/A
    EPS (ttm):-0.16
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUCDown 0.37%43.61M
    AGENDown 2.34%354.50M
    DNDNDown 13.61%N/A
    STMLDown 2.00%184.35M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.14
    Quarterly EPS Est (Mar-15) :-0.03
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback